PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
19673889-4	2009	Dofequidar fumarate, an orally active quinoline compound, has been reported to overcome MDR by inhibiting ABCB1/P-gp, ABCC1/MDR-associated protein 1, or both.	dofequidar	0-19	ATP binding cassette subfamily B member 1	Homo sapiens	106-111	
9788575-6	1998	MS-209 restored ADM incorporation and this effect was enhanced by CsA and VER, suggesting that these synergistic effects were due to competitive inhibition of P-gp function.	dofequidar	0-6	ATP binding cassette subfamily B member 1	Homo sapiens	159-163	
11197207-9	2000	The addition of MS-209 in vitro as an MDR-reversing agent significantly enhanced the intracellular daunorubicin/Rhodamine 123 accumulation and the retention of P-gp+ leukemic blast cells to a level similar to that of P-gp- blast cells.	dofequidar	16-22	ATP binding cassette subfamily B member 1	Homo sapiens	160-164	
11197207-9	2000	The addition of MS-209 in vitro as an MDR-reversing agent significantly enhanced the intracellular daunorubicin/Rhodamine 123 accumulation and the retention of P-gp+ leukemic blast cells to a level similar to that of P-gp- blast cells.	dofequidar	16-22	ATP binding cassette subfamily B member 1	Homo sapiens	217-221